5 Top 2017 Diabetes-CV Outcomes Studies

Slideshow

Five studies on the impact of diabetes drugs on CV outcomes get the editors' nod for the most promising results in 2017 diabetes research. Find out which 5! 

Five studies that evaluated the impact on cardiovascular outcomes of traditional and newer diabetes drugs are the Patient Care editors' choice for the most promising results in 2017 diabetes research.Click through the slides above for at-a-glance summaries of:CVD REAL CANVAS REMOVAL DEVOTE ODYSSEY-DM-INSULINLEADER (CV, renal)

Related Videos
Optimizing Diabetes Therapies with New Classifications
Vlado Perkovic, MBBS, PhD | Credit: George Institute of Global Health
Should We Reclassify Diabetes Subtypes?
What Should the American Academy of Physician Associates Focus on in 2025?
GLP-1 Agonist Safety Risks and Obesity Stigma with Kevin Peterson, MD, MPH
Video 8 - "Pathophysiology of Hypercortisolism"
Video 7 - "Evolving Perception of Autonomous Adrenal Hypercortisolism "
A panel of 5 experts on Cushing's syndrome
A panel of 5 experts on Cushing's syndrome
Laxmi Mehta, MD | Credit: American Heart Association
© 2024 MJH Life Sciences

All rights reserved.